Zur Pathogenese diabetischer Gefäßkomplikationen: Mögliche Beteiligung der nichtenzymatischen Glukosylierung von Proteinen

• LITERATUR

• 1 Wieland O. H. Zur Rolle der Hyperglyk-ämie in der Pathobiochemie des Diabetes mellitus. Verh. Dtsch. Ges. Inn. Med 1981; 87: 1
• 2 Wieland O. H. Protein modification by non-enzymatic glucosylation: Possible role in the development of diabetic complications. Mol. Cell Endocrin 1983; 29: 125
• 3 Bunn H. F. Nonenzymatic glycosylation of protein: Relevance to diabetes. Amer. J. Med 1981; 70: 325
• 4 Mehl T. D, Wenzel S. E, Russel B, Gardner D, Merimee T. J. Comparison of two indices of glycemic control in diabetic subject: Glycosylated serum protein and hemoglobin. Diabetes Care 1983; 6: 34
• 5 McDonald M. J, Bleichmann M, Bunn H. F, Noble R. W. Functional properties of the glycosylated minor components of human adult hemoglobin. J. Biol. Chem 1979; 254: 702
• 6 Ditzel J. Affinity Hypoxia as a pathogenic factor of microangiopathy with particular reference to diabetic retinopathy. Acta Endocrinol 1980; 94: 39
• 7 Samaja M, Melotti D, Carenini A, Pozza G. Glycosylated haemoglobins and the oxygen affinity of whole blood. Diabetolo-gia 1982; 23: 399
• 8 Williams S. K, Devenny J. J, Bitensky M. W. Micropinocytotic ingestion of glycosylated albumin by isolated microvessels: Possible role in pathogenesis of diabetic microangiopathy. Proc. Nat. Acad. Sci. USA 1981; 67: 2393
• 9 Jeray K. P, Michael A. F, Mauer S. M, Brown D. M. Glucosylated and normal human rat albumin do not bind to renal basement membranes of diabetic and control rats. Diabetes 1983; 32: 380
• 10 McVerry B. A, Hopp A, Fischer C, Huehns E. R. Production of pseudodiabetic renal glomerular changes in mice after repeated injections of glucosylated proteins. Lancet 1980; I: 738
• 11 Schleicher E, Deufel T, Wieland O. H. Non-enzymatic glycosylation of human serum lipoprotein: Elevated E-lysine glycosylated low density lipoprotein in diabetic patients. FEBS-Lett 1981; 129: 1
• 12 Goldstein J. L, Brown M. S. The low density lipoprotein pathway and its relation to atherosclerosis. Ann. Rev. Biochem 1977; 46: 897
• 13 Witztum J. L, Mahoney E. M, Branks M. J, Fisher M. J, Elam R, Steinberg D. Nonenzymatic glucosylation of low density lipoprotein alters its biologic activity. Diabetes 1982; 31: 283
• 14 Miller J. A, Gravallese E, Bunn H. F. Nonenzymatic glucosylation of erythrocyte membrane proteins: Relevance to diabetes. J. Clin. Invest 1980; 65: 896
• 15 Schleicher E, Scheller L, Wieland O. H. Quantitation of lysine-bound glucose of normal and diabetic erythrocyte membrane proteins by HPLC analysis of furosine. Biochem. Biophys. Res. Commun 1981; 99: 1011
• 16 Ernst E. Erythrozyten-Abnormalitäten beim Diabetes mellitus. Münchn. med. Wschr 1982; 124: 473
• 17 Schleicher E, Deufel T, Wieland O. H. Increase in membrane glycosylation and ADP permeability of diabetic erythrocytes. Diabetologia 1981; 21: 324
• 18 Schuyler M. R, Niewoehner D. E, Inkley S. R, Kohn R. Abnormal lung elasticity in juvenile diabetes mellitus. Am. Rev. Respir. Dis 1976; 113: 37
• 19 Rosenblom A. L, Silverstein J. H, Lezotte D. L, Richardson K, McCallum M. M. Limited joint mobility in childhood diabetes mellitus indicates increased risk for microvascular disease. New Engl. J. Med 1981; 305: 191
• 20 Lawson P. M, Maneschi E, Kohner E. M. The relationship of hand abnormalities to diabetes and diabetic retinopathy. Diabetes Care 1983; 6: 140
• 21 Cole G. W, Headley J, Skowsky R. Scleredema diabeticorum: A common and distinct cutaneous manifestation of diabetes mellitus. Diabetes Care 1983; 6: 189
• 22 Vogt B. W, Schleicher E. D, Wieland O. H. E-Amino lysine bound glucose in human tissues obtained at autopsy: Increase in diabetes mellitus. Diabetes 1982; 31: 1123
• 23 Schleicher E, Wieland O. H. Specific quantitation by HPLC of protein (lysine) bound glucose in human serum albumin and other glucosylated proteins: J. Clin. Chem. Clin. Biochem 1981; 19: 81
• 24 Wieland O. H, Dolhofer R, Schleicher E, Reindl E, Vogt B. Nonenzymatic glucosylation of proteins and possible pathophysiological consequences. In Reutter W. (ed.) Structural Carbohydrates in the Liver MTP Press Ltd. Lancaster in press;
• 25 Reindl E. Dissertationsarbeit, Universität München. 1983
• 26 Williams S. K, Howarth N. L, Devenny J. J, Bitensky M. W. Structural and functional consequences of increased tubulin glycosylation in diabetes mellitus. Proc. Nat. Acad. Sci. USA 1982; 79: 6546
• 27 Tsai C. S, White J. H. Activation of liver alcohol dehydrogenase by glycosylation. Biochem. J 1983; 209: 309
• 28 Dolhofer R, Siess E. A, Wieland O. H. Inactivation of bovine kidney B-N-acetyl-D-glucosaminidase by nonenzymatic glucosylation. Hoppe-Seyler’s Z. Physiol. Chem 1982; 363: 1427